Kodiak Sciences vs Oruka Therapeutics

Kodiak Sciences (KOD), health care, and Oruka Therapeutics (ORKA), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.

Oruka Therapeutics is worth $6.5B on the stock market and Kodiak Sciences $6.3B: Oruka Therapeutics is valued at 3% more. Over the past year Kodiak Sciences's share price has moved +424% and Oruka Therapeutics's +262%.

Key facts

Kodiak Sciences market value
$6.3B
Oruka Therapeutics market value
$6.5B
Superinvestors holding both
1

Market values as of .

Kodiak Sciences vs Oruka Therapeutics: every measure side by side
Measure Kodiak Sciences Oruka Therapeutics
SectorHealth CareHealth Care
Country United States United States
Fiscal year ends2025-12-312025-12-31
Size
Market cap$6.3Blower$6.5Bhigher
Revenue——
Earnings-$230Mlower-$105.4Mhigher
Employees141higher68lower
Total assets$351.5Mlower$488.6Mhigher
Valuation
P/E——
P/S——
P/B494higher5.4lower
Dividend yield0.00%0.00%
Profitability
Operating margin——
Balance sheet
Net assets$157.4Mlower$471.9Mhigher
Total liabilities$194.2Mhigher$16.7Mlower
Total debt——
Cash on hand$209.9Mhigher$46.9Mlower
Price change
Today-3.90%lower-2.94%higher
1 year+424%higher+262%lower

Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.

Loading the one-year price chart…

Which superinvestors hold them

From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.

Both (1)

Kodiak Sciences only (1)

Oruka Therapeutics only (2)

Percentages are each holding's share of that investor's reported portfolio (under "Both": Kodiak Sciences / Oruka Therapeutics). Who owns KOD · Who owns ORKA

Further comparisons

Learn

Questions and answers

Which is bigger, Kodiak Sciences or Oruka Therapeutics?

By market value, Oruka Therapeutics is the larger: $6.5B against $6.3B for Kodiak Sciences.

Which has the higher dividend yield?

Neither: both stand at 0.00%. Dividend yield is the last twelve months' dividends as a share of today's share price.

Which superinvestors own both Kodiak Sciences and Oruka Therapeutics?

In their latest 13F filings, Polen Capital team holds both.

Cite this page

Funkfolio, “Kodiak Sciences vs Oruka Therapeutics”, data as of 18 November 2026. https://funkfolio.com/compare/kod-vs-orka

Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.